๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical evaluation of DNA index in human brain tumors

โœ Scribed by Takafumi Nishizaki; Noboru Ohshita; Yoshio Nagatsugu; Tetsuji Orita; Haruhide Ito; Kohsuke Sasaki


Publisher
Springer US
Year
1993
Tongue
English
Weight
382 KB
Volume
17
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cytogenetic studies of human brain tumor
โœ Frederick R Latimer; Abdul A AlSaadi; Thomas O Robbins ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 315 KB

Four medulloblastomas were studied cytogenetically with clinical follow-up of the patients. Three of these lesions were diploid and the patients manifested no recurrence at 40, 37 and 36 months respectively. The remaining tumor was aneuploid with 52 chromosomes and the patient expired of the medullo

Evaluation and clinical value of neuroen
โœ Cussenot, Olivier; Villette, Jean-Marie; Cochand-Priollet, Beatrix; Berthon, Phi ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 363 KB ๐Ÿ‘ 2 views

## BACKGROUND. Prostate cancer, like other solid tumors, is a rather heterogeneous entity. More than 50% of all malignant prostatic tumors contain neuroendocrine-like cells, which cannot be attributed to small cell prostatic carcinoma or carcinoid-like tumors, which represent only 1-2% of all prost

Comprehensive phase II evaluation of Azi
โœ Robert T. Eagan; Robert P. Dinapoli; Terrence L. Cascino; Bernd Scheithauer; Bri ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 411 KB

Ninety-three patients with primary intracranial brain tumors recurrent after cerebral irradiation were treated with aziridinylbenzoquinone (AZQ; Diaziquone). Twenty-four (26%) had tumor regression lasting a median of 9.2 months. Prior chemotherapy was not significantly associated with tumor regressi